Sirolimus eluting coronary stent system, with CoCr Stent and permanent polymer - India CDSCO Medical Device Registration

Sirolimus eluting coronary stent system, with CoCr Stent and permanent polymer is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2022/000268_95a1678a882ce75f273e1b9a5a4f4e1a_ee4d6b6d73d6c216473a304fc3dccbdf. This device is marketed under the brand name iVascular angiolite. The license holder is M/s. B.V Enterprise, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class D

Sirolimus eluting coronary stent system, with CoCr Stent and permanent polymer

UID: IMP/MD/2022/000268_95a1678a882ce75f273e1b9a5a4f4e1a_ee4d6b6d73d6c216473a304fc3dccbdf

Brand Name

iVascular angiolite

License Holder

M/s. B.V Enterprise

Device Class

Class D

Approving Authority

CDSCO

Product Information

The device is indicated for increasing the internal diameter of an artery with the aim of improving blood flow in the following cases: • Patients with symptomatic ischemic heart disease due to “de novo” stenotic and re-stenotic lesions located in arteries with diameters from 2mm to 4.5mm. • Patients with occlusive disease due to acute myocardial infarction located in arteries with diameters from 2mm to 4.5mm